Four versus two years of Rituximab maintenance (R-maintenance) following Bendamustine plus Rituximab (B-R): initial results of a prospective, randomized multicenter phase 3 study in first-line follicular lymphoma (the StiL NHL7-2008 MAINTAIN study)

Authors :: Rummel, M.
Buske, C.
Hertenstein, B.
Lerchenmüller, C. A.
Koenigsmann, M.
Lange, E.
Reeb, M.
Kaiser, U.
Balser, C.
Behringer, D.
Dürig, Jan
Gaska, T.
Maschmeyer, G.
Schliesser, G.
Burchardt, A.
Barth, J.
Kauff, F.
Hinke, A.
Greil, R.
Publication Year :: 2018

Tools